Status:
COMPLETED
Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Cystic Fibrosis,
Eligibility:
All Genders
4-45 years
Brief Summary
Chronic bronchial inflammation is an important clinical feature in cystic fibrosis. Approximately 10% of patients with cystic fibrosis suffer from Allergic Bronchopulmonary Aspergillosis. In addition ...
Detailed Description
Since symptoms of Bronchopulmonary Aspergillosis are often identical to bacterial infections, the diagnosis is difficult to make. The disease presents with wheezing, pulmonary infiltrates, and bronchi...
Eligibility Criteria
Inclusion
- informed consent
- age between 4 and 45 years
- well-known Cystic fibrosis
- Lung function: FEV1 (% pred.) ≥ 70%
Exclusion
- age \< 4 and \> 45 years
- lung function: FEV1 (% pred.)\< 70%
- other chronic diseases or infections (e.g., HIV, tuberculosis, malignancy)
- pregnancy
- known alcohol, drug and/or drug abuse
- inability to capture the scale and scope of the study
- participation in another study
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00906568
Start Date
April 1 2009
End Date
August 1 2010
Last Update
February 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Goethe-University Hospital
Frankfurt am Main, Hesse, Germany, 60590